The ADVATx Laser Platform Built for Results and Built for Clinics Like Yours.Â
Tired of switching machines for every indication? ADVATx combines the power of 589 nm and 1319 nm wavelengths to treat acne, rosacea, pigment, scars, redness, and more all with no pain, no disposables, and no recovery time.Â
Clinics across the GCC are replacing their COâ‚‚ and IPL devices with this single, elegant system.Â
ADVATx is the world’s first dual-wavelength laser platform delivering off-the-table results with zero recovery time.Â
With 25+ FDA/CE cleared indications and a single scanner handpiece, ADVATx treats:
No anesthesia. No disposables. No downtime.Â
ADVATx isn’t just effective it’s easy to use.Â
Safe for all skin types. Built for high-throughput clinics. No gels. No tips. No surprises.Â
ROI starts on day one. Your team will love using it.Â
Treat more conditions, more comfortably and more profitably.Â
ADVATx helps clinics:Â
Reduce per-session costs (zero consumables)Â
Increase treatment throughput (fast & flexible)Â
Maximize revenue from one deviceÂ
Treat more patients year-roundÂ
Scale without increasing clinical burdenÂ
Clinics across the GCC see ROI in as little as 6–9 months. Â
With numerous FDA and CE cleared indications ranging from vascular abnormalities to acne, wrinkle reduction and warts, ADVATx is poised to become the laser modality of choice for physicians dedicated to offering their patients the most advanced laser solutions available.
Â
Real Results. Real Clinics. Real Patients.Â
Our patients ask for ADVATx by name. The results speak for themselves.
Soothe Redness. Restore Confidence.Â
Using the 589 nm wavelength, ADVATx targets visible redness and inflamed capillaries associated with rosacea. The treatment calms the skin by shrinking superficial vessels and reducing chronic inflammation with no bruising, pain, or downtime.Â
Ideal for patients seeking visible results without medication or IPL discomfort.Â
Combining 589 and 1319nm wavelengths initiates an inflammatory response by targeting superficial vasculature while at the same time causing thermal injury to the papillary dermis, initiating the body’s natural wound healing response, stimulating fibroblast activity and the formation of Type 1 and 3 collagen, resulting in visible improvement to tone and texture.
By targeting the p.acne bacteria itself, the vascular component to active lesions and the underlying oil production by the sebaceous glands, the ADVATx employs a multi-pronged approach to reducing active acne.
The ideal ratio of oxyhemoglobin to melanin absorption of 589nm, coupled with the PulSync delivery system, provides for the ability to safely and effectively treat a broad range of vascular abnormalities without patient downtime.
By addressing the underlying vascular components with 589nm and the sebaceous gland component with 1319nm, melasma is targeted on multiple fronts. The absorption characteristics and delivery mechanism allow treatment with a low risk of PIH.
Worldwide, millions of people are bothered by the appearance of vascular lesions, melasma*, rosacea, acne, wrinkles and scars. These conditions are associated with negative impact on quality of life and may result in psychological morbidity. Laser therapy has proven to be efficient in reducing and resolving many of these unwanted conditions, thereby improving patients’ quality of life.
Off the table, long lasting results for multiple indications
Number of treatments : 1TxÂ
Photo Courtesy :Â Arizona Facial Plastics
Number of treatments : 1TxÂ
Photo Courtesy :Â Aspire Medical Spa
*CE cleared indication
Number of treatments : 1TxÂ
Photo Courtesy : All About Beauty
Number of treatments : 1Tx
Photo Courtesy : Carsten M. Philipp, MD
Number of treatments : 1TxÂ
Photo Courtesy : Marek Jankowski, MD
Number of treatments : 1TxÂ
Photo Courtesy : Arizona Facial Plastics
Number of treatments : 1TxÂ
Photo Courtesy : Carsten M. Philipp, MD
© 2026 Arabian Medical Enterprises . All Rights Reserved